| Application no. and date | 20755296.9 (espacenet) (Federated) (European Patent Register), 20200212 | | Patent/reg. no. and date | DK/EP 3923943, 20240731 | | Publication date | 20211222 | | Priority no. and date | US 201962804523 P, 20190212, US 201962863904 P, 20190620, US 201962908431 P, 20190930, US 201962932015 P, 20191107 | | EP pub. no. and date |
EP 3923943 20211222 | | Effective date | | | Applicant/owner | Mirum Pharmaceuticals, Inc., 989 E Hillsdale Blvd., Suite 300
Foster City, CA 94404, US | | Applicant ref. no. | V478746DK00 | | Inventor | DORENBAUM, Alejandro, 120 Stanford Avenue
Mill Valley, CA 94941, US,
JAECKLIN, Thomas, 1, rue du Jura
2800 Delemont, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4995 (2006.01) , A61K 31/554 (2006.01) , A61K 31/7042 (2006.01) , A61K 38/05 (2006.01) , A61P 1/16 (2006.01) , A61P 17/04 (2006.01) | | Title | Genotype og dosisafhængig respons til en ASBTI i patienter med galdesalteksportpumpemangel | | Int. application no. | US2020017951 | | Int. publication no. | WO2020167964 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
